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Abstract
Background: Mycoplasma pneumoniae is responsible for more than 20% of community acquired
pneumonia cases, and capable of causing upper respiratory illness as well. Complications of
M.pneumoniae infections include CNS involvement but other as pericarditis were also reported.
The lack of feasible culture methods and under appreciation of the pathogens ability to cause
invasive disease leads to reduced number of diagnosed M.pneumoniae related complications. In
contrast to many other respiratory pathogens causing pneumonia, M. pneumoniae related severe
pleural complications were almost never reported.
Case presentation: We report a previously healthy 57 years old woman presented with indolent
massive right pleural effusion, leukocytosis and elevated ESR. Extensive microbiological evaluation
didn't reveal any pathogen in the pus even before antibiotic treatment was started. Surprisingly,
M.pneumoniae DNA was detected in the pus from the empyema using PCR designed to detect
M.pneumoniae. A serological assay (Serodia-Myco II) using convalescent serum was indeterminate
with a titer of 1:80. The patient responded well to a treatment that included right thoracotomy
with pleural decortication and a combination of antibiotics and anti-inflammatory medications.
Conclusion: M.pneumoniae related empyema was never reported before in adult patients and was
reported in only a few pediatric patients. In our patient there was no evidence to any common
pathogens even before initiating antibiotic treatment. The only pathogen detected was
M.pneumoniae. In this patient, serology was not helpful in establishing the diagnosis of M.pneumoniae
related diseases, as was suggested before for older patients. We suggest that M.pneumoniae related
empyema is probably under-diagnosed complication due to insensitivity of serology in older
patients and under use of other diagnosis methods.
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Background
Mycoplasma pneumoniae is one of the most common respi-
ratory pathogens [1]. Generally, it causes mild respiratory
diseases managed by primary care physicians. The most
common presentation is community acquired pneumo-
nia in which it is responsible for more than 20% of cases,
but is responsible as well for upper respiratory illness [1].
There are few very well documented complications caused
by this pathogen. These mainly include CNS involvement
but other complications as pericarditis are also reported
[1]. There are a few reasons for the lack of evidence for
M.pneumoniae involvement in complications of respira-
tory infections, such as: under appreciation of the patho-
gen as being able to cause invasive disease, and the lack of
feasible culture methods as is the case with other patho-
gens [1,2]. Currently, diagnosis of M.pneumoniae infection
[1-3] is based either on serology with it's limitations or
PCR performed on clinical specimens – but the last
method is not widely available in clinical microbiology
labs. Here we report a case of massive empyema in adult
patient caused by M.pneumoniae – a condition that was
not reported before in this age group.
Case presentation
A previously healthy 57 years old woman admitted to our
hospital due to dyspnoea. Two weeks before admission
she had right sided pleural pain followed by dyspnoea,
without cough and without fever, these increased with
time and therefore she referred herself to the hospital. Her
physical examination suggested right sided pleural effu-
sion, laboratory tests showed leukocytosis (WBC-19000/
mm3  with 89% neutrophils), HGB-12.5 g/dL, platelet
count 400,000 platelets/mm3, and erythrocyte sedimen-
tation rate 34 mm/hour. C-reactive protein level was
highly elevated – 45 mg/dL (normal range 0–0.5 mg/dL).
The results of chemistry panel were normal except for
mildly elevated alkaline phosphatase – 157 u/l (40–130
u/l).
A chest CT performed on admission (figure 1) showed
massive right pleural effusion, with right lung athelectasis.
Chest tube was inserted to the pleural cavity and evacu-
ated only small amount of purulent fluid, although strep-
tokinase was injected to the pleural cavity four times.
Antibiotic treatment was started using IV Cefuroxime
(750 mg three times a day) and oral Roxithromycin (150
mg twice a day) for 4 days without signs of improvement.
A repeated CT performed 4 days after admission, showed
a massive amount of right sided pleural effusion with
right middle and lower lobe athelectasis. Therefore, a right
sided thoracotomy was performed. A significant amount
of pus and fibrin was drained during the procedure, and
the lung expanded normally after the pleura was decorti-
cated on that side. Pus from the empyema (before and
after starting antibiotic treatment) was cultured several
times both for common pathogens as well as Mycobacte-
ria but turned to be negative. Pathological examination of
the pleura that was removed during the procedure showed
fibrotic pleura covered by pus and fibrin without evidence
for any organism. Given the clinical gradual and atypical
course of the patient with the negative stains and cultures
results, the pleural pus and fluid were also tested for
M.pneumoniae using PCR. DNA was extracted from the pus
using the DNAeasy tissue kit (Qiagen, Hilden, Germany).
First we have utilised a Mycoplasma genus specific PCR
amplifying 16SRNA DNA, doing direct amplification
using the same thermal profile and GPO-3/MGSO prim-
ers as described in ref [4]. In this test one negative and one
positive controls were used for 10 samples. Surprisingly a
positive typical band at the size of ~270 bp was found,
suggesting the presence of Mycoplasma spp. in the sample.
Therefore, we further used two sets of M.pneumoniae spe-
cie specific PCR reactions to identify if it is M.pneumoniae.
The first was a nested PCR using the primers of the ATPase
gene in the same conditions as described in ref [5]. This
test was shown in our lab to have a detection limit of ~20
CFU/ml (Nir-Paz et al. data on file). Two negative controls
were included for every 8 samples tested in order to
exclude contaminations during the nested reaction as well
as a positive control for 16 reactions. This test gave a typi-
cal band at the size of 104 bp suggesting that the existence
of  M.pneumoniae. In order to confirm that finding, we
have performed another M.pneumoniae specific PCR using
the P1 gene. A direct PCR using the same primers and con-
ditions as described in Ref [6] was performed. In this test
one negative and one positive controls were used for 10
samples. Again this PCR gave a typical positive band at the
size of 466 bp, confirming the presence of M.pneumoniae
Chest CT scan Figure 1
Chest CT scan. Chest CT scan of the patient showing mas-
sive right side pleural effusion with atelctasis of the lung.BMC Infectious Diseases 2006, 6:18 http://www.biomedcentral.com/1471-2334/6/18
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DNA in the sample. Unfortunately, only convalescent
serum that was taken 30 days after the initial admission
was available for serology, and it was indeterminate with
a titer of 1:80 using the Serodia-Myco II assay (Fujirebio,
Tokyo, Japan), and IgM negative using Mycoplasma pneu-
moniaea IgM EIA (ANILabsystems, Helsinki, Finland).
After the surgery, the patient was gradually recovered with
intravenous azythromycin treatment (500 mg once a day)
for 10 days followed by 5 more days of oral therapy (250
mg once a day), In addition she was treated with oral
Pyranocarboxylate (400 mg twice a day) for the first two
weeks after surgery.
The CRP level dropped to 9.5 mg/dl after the operation
and two weeks later, the CRP level decreased into normal
levels (0.2 mg/dl). At this time point the patient fully
recovered without any breath or pain complaints and no
residual fluid was seen in the chest X -ray.
Discussion
We presented a case of Mycoplasma pneumoniae related
massive pyogenic pleural effusion. There was no evidence
of other causative agents in repeated stains, cultures or
pathological examination of the pleura before and after
the patient received antibiotics.
M. pneumoniae infections involves upper respiratory air-
way, lower respiratory airway or both; symptomatic dis-
ease typically develops gradually over a period of several
days or weeks [1]. Bronchopneumonia involving one or
more lobes develops in 3–10% of infected patients, while
bilateral involvement occurs in about 20% of cases [1].
Minimal pleural effusion were suggested a few decades
ago [7] in up to 20% of the patients when lateral decubi-
tus films were performed, but diagnosis was based on cold
agglutinin or complement fixation titers. Moreover, none
of the patients in that study had any evidence of
empyema. Few severe cases with significant pleural effu-
sion and necrotizing pneumonia were reported in chil-
dren [8]. Recently, two studies in these pediatric patients
suggested that at least two distinct patterns of M.pneumo-
niae  related pleural effusion [9,10]: the first is more
benign, most probably reactive and does not contain
M.pneumoniae DNA. The other, involves protracted dis-
ease and contains M.pneumoniae DNA. The pathogenesis
of pleural effusion is still unclear, but the authors specu-
late that the presence of the DNA may elicit stronger
immunologic reaction causing lung damage, with IL-8
and IL -18 play a role in the reaction [11,12]. In extensive
literature search, no reports describing M.pneumoniae
associated empyema in adult or elderly patients were
found.
M.pneumoniae related empyema is currently considered a
rare complication. Our case is unique by the old age of our
patient and characterized by a subacute progress of a pul-
monary disease. A massive empyema which requires tho-
racotomy and decortication, was never reported for this
pathogen in this patient's age. Apparently, as was sug-
gested before, serology in older people does not serve as a
useful tool to support such diagnosis [13]. Nevertheless, it
might be that M.pneumoniae  is a common cause of
empyema complicating respiratory infection and pneu-
monia but is under-diagnosed due to the use of insensi-
tive diagnostic methods. We conclude that M.pneumoniae
should be thought as an etiologic agent for respiratory
infection followed by empyema in older patients. This
should probably be confirmed by the use of PCR or by the
use of other DNA based methods.
Conclusion
In this case report we describe the first reported empyema
caused by Mycoplasma pneumoniae in an adult. M.pneumo-
niae is one of the common respiratory pathogens, how-
ever due to it's fastidious nature it is not commonly
detected. Therefore we suggest that M.pneumoniae related
empyema is probably an under-diagnosed complication
due to insensitivity of serology in older patients and under
use of other diagnosis methods.
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